| scholarly article | Q13442814 |
| P50 | author | Guido von Figura | Q63133710 |
| P2093 | author name string | Haruhiko Akiyama | |
| Christopher V E Wright | |||
| Kristin Jensen | |||
| Maike Sander | |||
| John P Morris | |||
| Matthias Hebrok | |||
| Claire L Dubois | |||
| Janel L Kopp | |||
| Fong Cheng Pan | |||
| Erin Mayes | |||
| Fen-Fen Liu | |||
| P2860 | cites work | Identification of a cell of origin for human prostate cancer | Q24594400 |
| Activated Notch1 target genes during embryonic cell differentiation depend on the cellular context and include lineage determinants and inhibitors | Q27324100 | ||
| Sox9b is a key regulator of pancreaticobiliary ductal system development | Q27333515 | ||
| Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group | Q28307042 | ||
| The group E Sox genes Sox8 and Sox9 are regulated by Notch signaling and are required for Müller glial cell development in mouse retina | Q28509860 | ||
| SOX9 is required for maintenance of the pancreatic progenitor cell pool | Q28510325 | ||
| A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation | Q28510770 | ||
| EGF receptor is required for KRAS-induced pancreatic tumorigenesis | Q28584901 | ||
| Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas | Q28584996 | ||
| Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice | Q29617045 | ||
| Cells of origin in cancer | Q29619557 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas | Q33591500 | ||
| Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice | Q33604913 | ||
| Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia | Q33754775 | ||
| Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice | Q61776577 | ||
| Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis | Q73614651 | ||
| Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model | Q33818230 | ||
| Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras | Q34082522 | ||
| Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer | Q34241383 | ||
| Genetics and biology of pancreatic ductal adenocarcinoma. | Q34567515 | ||
| Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras | Q34620985 | ||
| Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma | Q34642090 | ||
| Nkx6 transcription factors and Ptf1a function as antagonistic lineage determinants in multipotent pancreatic progenitors. | Q35097448 | ||
| Hedgehog/Ras interactions regulate early stages of pancreatic cancer | Q35127709 | ||
| The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia | Q35663506 | ||
| The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis. | Q35921887 | ||
| Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia | Q35928158 | ||
| A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation | Q36058628 | ||
| In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia | Q36478584 | ||
| EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma | Q36696146 | ||
| Molecular genetics of pancreatic intraepithelial neoplasia | Q36829524 | ||
| Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia | Q36980230 | ||
| Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice | Q36999854 | ||
| Stabilization of beta-catenin induces pancreas tumor formation | Q37034716 | ||
| Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia | Q37249748 | ||
| Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia | Q37501557 | ||
| PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network | Q38626764 | ||
| Pancreatic Intraepithelial Neoplasia | Q38720267 | ||
| Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. | Q39337159 | ||
| Notch1 signaling regulates chondrogenic lineage determination through Sox9 activation | Q39484183 | ||
| Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma | Q39885220 | ||
| SOX9cre1, a cis-acting regulatory element located 1.1 Mb upstream of SOX9, mediates its enhancement through the SHH pathway | Q40149526 | ||
| Hedgehog signaling is required for effective regeneration of exocrine pancreas | Q41761890 | ||
| Zebrafish sox9b is crucial for hepatopancreatic duct development and pancreatic endocrine cell regeneration | Q41791253 | ||
| Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia | Q41816001 | ||
| Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling | Q41858645 | ||
| Sox9+ ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. | Q41979160 | ||
| Notch signaling controls liver development by regulating biliary differentiation | Q42080795 | ||
| Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors | Q42473171 | ||
| Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. | Q42876632 | ||
| Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth | Q43199149 | ||
| Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration | Q46376132 | ||
| Pten constrains centroacinar cell expansion and malignant transformation in the pancreas | Q46708964 | ||
| The Onecut transcription factor HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream of Pdx-1 in the specification cascade | Q47867912 | ||
| Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. | Q51056982 | ||
| Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. | Q52172849 | ||
| Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. | Q53329413 | ||
| The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. | Q53379869 | ||
| P433 | issue | 6 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 737-750 | |
| P577 | publication date | 2012-11-29 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | |
| P478 | volume | 22 |
| Q92905126 | A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma |
| Q28082890 | A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas |
| Q90950168 | A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells |
| Q36911550 | A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling |
| Q35801362 | A concise review on the current understanding of pancreatic cancer stem cells |
| Q93018032 | A model for RAS mutation patterns in cancers: finding the sweet spot |
| Q64113087 | A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal |
| Q30669159 | A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics |
| Q91711463 | ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis |
| Q41322585 | ATM-deficiency increases genomic instability and metastatic potential in a mouse model of pancreatic cancer |
| Q38922230 | Acinar cell plasticity and development of pancreatic ductal adenocarcinoma |
| Q38459854 | Acinar cell reprogramming: a clinically important target in pancreatic disease |
| Q42282476 | Acinar cells in the neonatal pancreas grow by self-duplication and not by neogenesis from duct cells |
| Q41105264 | Acinar-to-Ductal Metaplasia Induced by Transforming Growth Factor Beta Facilitates KRASG12D-driven Pancreatic Tumorigenesis. |
| Q38222722 | Activated K-RAS and its effect on morphological appearance. |
| Q90076561 | Activation of the intrinsic fibroinflammatory program in adult pancreatic acinar cells triggered by Hippo signaling disruption |
| Q34046479 | Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style |
| Q64109969 | Adult human pancreatic acinar cells dedifferentiate into an embryonic progenitor-like state in 3D suspension culture |
| Q90240762 | Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer |
| Q39261074 | Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. |
| Q96136047 | An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development |
| Q37053079 | An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. |
| Q51209052 | Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation. |
| Q37628092 | Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas |
| Q36017810 | Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics |
| Q36169365 | Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration |
| Q64098116 | Antibodies to a CA 19-9 Related Antigen Complex Identify SOX9 Expressing Progenitor Cells In Human Foetal Pancreas and Pancreatic Adenocarcinoma |
| Q55713410 | Arid1a restrains Kras-dependent changes in acinar cell identity. |
| Q46862467 | Atypical flat lesions derive from pancreatic acinar cells |
| Q89583666 | BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma |
| Q35228755 | Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation |
| Q47690405 | CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A. |
| Q26261171 | Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions |
| Q90566625 | Carcinogenesis of Pancreatic Ductal Adenocarcinoma |
| Q33767473 | Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity |
| Q92410874 | Cells of Origin for Prostate Cancer |
| Q39161835 | Cells of origin of pancreatic neoplasms |
| Q92118472 | Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution |
| Q42532386 | Change isn't always better |
| Q58612678 | Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness |
| Q44907312 | Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma |
| Q50027269 | Comprehensive characterisation of compartment-specific long non-coding RNAs associated with pancreatic ductal adenocarcinoma. |
| Q27021239 | Control of cell identity in pancreas development and regeneration |
| Q35612378 | Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer |
| Q93147190 | Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice |
| Q26774942 | Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin |
| Q38815842 | Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. |
| Q35432049 | Dicer is required for maintenance of adult pancreatic acinar cell identity and plays a role in Kras-driven pancreatic neoplasia |
| Q35161464 | Dicer regulates differentiation and viability during mouse pancreatic cancer initiation |
| Q91925131 | Differential Cell Susceptibilities to KrasG12D in the Setting of Obstructive Chronic Pancreatitis |
| Q39384816 | Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis |
| Q37624230 | Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis |
| Q41845030 | Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia |
| Q33635144 | Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm |
| Q34246014 | Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma |
| Q47111525 | Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression. |
| Q90139280 | Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma |
| Q55616605 | E47 Governs the MYC-CDKN1B/p27KIP1-RB Network to Growth Arrest PDA Cells Independent of CDKN2A/p16INK4A and Wild-Type p53. |
| Q41931284 | ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation |
| Q52357887 | ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis. |
| Q34517664 | Effects of insulin on human pancreatic cancer progression modeled in vitro |
| Q47121552 | Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice. |
| Q28391884 | FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma |
| Q58697838 | Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer |
| Q37711618 | Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction. |
| Q45234060 | GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras-driven pancreatic tumorigenesis in mice |
| Q37343012 | Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia. |
| Q49723851 | Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury |
| Q27002973 | Genetically engineered mouse models of pancreatic adenocarcinoma |
| Q26765438 | Genetics and biology of pancreatic ductal adenocarcinoma |
| Q91675150 | Genome-Wide identification of doublesex and Mab-3-Related transcription factor (DMRT) genes in nile tilapia (oreochromis niloticus) |
| Q30847630 | HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche |
| Q50897116 | HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer. |
| Q56530315 | HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties |
| Q90185432 | HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer |
| Q38119462 | Hacking cell differentiation: transcriptional rerouting in reprogramming, lineage infidelity and metaplasia |
| Q87225930 | Hepatocytes as a source of cholangiocytes in injured liver |
| Q91297699 | Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis |
| Q41770555 | Identification and manipulation of biliary metaplasia in pancreatic tumors. |
| Q37476029 | Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia |
| Q41854156 | Impact of Sox9 dosage and Hes1-mediated Notch signaling in controlling the plasticity of adult pancreatic duct cells in mice. |
| Q40730244 | Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma. |
| Q55252335 | In vivo reprogramming drives Kras-induced cancer development. |
| Q37068621 | Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma |
| Q55516479 | Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment. |
| Q28504893 | Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance |
| Q41070965 | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
| Q92557598 | Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer |
| Q91789132 | Is there a CDKN2A-centric network in pancreatic ductal adenocarcinoma? |
| Q38786245 | KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis |
| Q100428129 | Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer |
| Q40291371 | Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells |
| Q49722539 | Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar to Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice |
| Q36364191 | LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer |
| Q61714951 | Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling |
| Q53176733 | Liver and pancreas: do similar embryonic development and tissue organization lead to similar mechanisms of tumorigenesis? |
| Q92060321 | Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis |
| Q35941554 | Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition |
| Q37730619 | Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia |
| Q39014544 | Loss of HNF6 expression correlates with human pancreatic cancer progression |
| Q47259787 | Loss of PTEN and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice |
| Q36546501 | Loss of p27Kip¹ promotes metaplasia in the pancreas via the regulation of Sox9 expression |
| Q53215067 | Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer. |
| Q47246517 | Luteolin inhibits pancreatitis‑induced acinar‑ductal metaplasia, proliferation and epithelial‑mesenchymal transition of acinar cells. |
| Q33680759 | MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice |
| Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
| Q38680703 | Macrophages and pancreatic ductal adenocarcinoma |
| Q37071747 | Macrophages in pancreatic cancer: starting things off on the wrong track |
| Q90199031 | Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress |
| Q36271527 | Mesoderm-specific Stat3 deletion affects expression of Sox9 yielding Sox9-dependent phenotypes. |
| Q57067700 | Metabolism and Epigenetics of Pancreatic Cancer Stem Cells |
| Q47786705 | Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence |
| Q91871177 | Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture |
| Q39441268 | Molecular Events in the Natural History of Pancreatic Cancer |
| Q38434627 | Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma |
| Q91341271 | Molecular subtypes of pancreatic cancer |
| Q38916311 | NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas. |
| Q36367008 | NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation |
| Q38683437 | Neat1 is a p53-inducible lincRNA essential for transformation suppression |
| Q38907393 | New insights in the development of pancreatic cancer |
| Q46948614 | New role of endoplasmic reticulum chaperones in regulating metaplasia during tumorigenesis. |
| Q38299502 | Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer |
| Q38094850 | Notch signaling in pancreatic cancer: oncogene or tumor suppressor? |
| Q39156056 | Nr5a2 maintains acinar cell differentiation and constrains oncogenic Kras-mediated pancreatic neoplastic initiation |
| Q64086685 | Obesogenic high-fat diet heightens aerobic glycolysis through hyperactivation of oncogenic KRAS |
| Q51049205 | Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes. |
| Q33810570 | Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia |
| Q34456438 | Organoid models of human and mouse ductal pancreatic cancer |
| Q99548635 | Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation |
| Q37587988 | PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance |
| Q90371583 | PRDM3 attenuates pancreatitis and pancreatic tumorigenesis by regulating inflammatory response |
| Q59092532 | Pancreas regeneration |
| Q26765235 | Pancreatic Cancer Genetics |
| Q36311734 | Pancreatic Cancer Metastases Harbor Evidence of Polyclonality |
| Q55104265 | Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. |
| Q52661910 | Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice. |
| Q41915274 | Pancreatic Ductal Adenocarcinoma in a Wistar Hannover GALAS Rat |
| Q58759701 | Pancreatic Exocrine Tissue Architecture and Integrity are Maintained by E-cadherin During Postnatal Development |
| Q52564462 | Pancreatic HIF2α Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm. |
| Q40053687 | Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report |
| Q92435020 | Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus |
| Q57423198 | Pancreatic cancer |
| Q26747524 | Pancreatic cancer from bench to bedside: molecular pathways and treatment options |
| Q27322787 | Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing |
| Q34590266 | Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α |
| Q92504704 | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
| Q34656874 | Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop |
| Q50118423 | Paracrine Secretion of Transforming Growth Factor β by Ductal Cells Promotes Acinar-to-Ductal Metaplasia in Cultured Human Exocrine Pancreas Tissues. |
| Q59281988 | Parp-1genetic ablation inEla-mycmice unveils novel roles for Parp-1 in pancreatic cancer |
| Q37589374 | Pathogenesis of pancreatic cancer: lessons from animal models |
| Q38260683 | Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments |
| Q41681299 | Perfluorooctanoic acid exposure triggers oxidative stress in the mouse pancreas |
| Q39204274 | Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. |
| Q38666705 | Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer |
| Q41737306 | Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease |
| Q52900209 | Progenitor cell niches in the human pancreatic duct system and associated pancreatic duct glands: an anatomical and immunophenotyping study. |
| Q42750201 | Proteasome activity is required for the initiation of precancerous pancreatic lesions. |
| Q35376826 | Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia |
| Q36327192 | Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease |
| Q36700012 | Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation |
| Q45415868 | Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk |
| Q93035794 | Putting the Cell of Origin for Pancreatic Cancer Into its Proper Context |
| Q42253007 | Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma |
| Q35071666 | Regeneration and repair of the exocrine pancreas |
| Q52543005 | Regenerative medicine and cell-based approaches to restore pancreatic function. |
| Q28086849 | Regulation of Cellular Identity in Cancer |
| Q89151862 | Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer |
| Q41738818 | Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment. |
| Q64075442 | Regulation of the Pancreatic Exocrine Differentiation Program and Morphogenesis by Onecut 1/Hnf6 |
| Q43657200 | Reply: To PMID 23315998. |
| Q89748434 | Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties |
| Q26801731 | Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tract |
| Q59799222 | Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors |
| Q36280897 | Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis |
| Q36716930 | Role of β-catenin in development of bile ducts. |
| Q34786506 | SOX10, a novel HMG-box-containing tumor suppressor, inhibits growth and metastasis of digestive cancers by suppressing the Wnt/β-catenin pathway |
| Q43083428 | SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types |
| Q41048622 | SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells |
| Q64095213 | SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer |
| Q47616426 | SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer |
| Q38780862 | SOX9 drives WNT pathway activation in prostate cancer |
| Q27341897 | SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties |
| Q37336985 | SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. |
| Q92668907 | SOX9 promotes tumor progression through the axis BMI1-p21CIP |
| Q53229089 | SOX9 regulates ERBB signalling in pancreatic cancer development. |
| Q49382495 | SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance |
| Q37621990 | SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms |
| Q49388105 | ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. |
| Q57471060 | SWI/SNF component restrains pancreatic neoplasia formation |
| Q64890448 | Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis. |
| Q27334054 | Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis |
| Q37315252 | Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells |
| Q91622915 | Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma |
| Q99248315 | Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells' heterogeneity |
| Q42457687 | Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia |
| Q33976991 | Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma |
| Q34972366 | Sox9: a master regulator of the pancreatic program |
| Q42264292 | Specific transduction and labeling of pancreatic ducts by targeted recombinant viral infusion into mouse pancreatic ducts. |
| Q36423795 | Spontaneous Pancreatitis Caused by Tissue-Specific Gene Ablation of Hhex in Mice |
| Q58747287 | Stabilization of HIF-2α impacts pancreas growth |
| Q38748909 | Stem cells versus plasticity in liver and pancreas regeneration. |
| Q46092740 | Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas |
| Q37273793 | Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia |
| Q34002580 | Stromal response to Hedgehog signaling restrains pancreatic cancer progression |
| Q48838047 | Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. |
| Q37147887 | TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells |
| Q50640303 | The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer. |
| Q56967209 | The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis |
| Q65002383 | The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice. |
| Q36621889 | The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis |
| Q30276749 | The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype |
| Q35954277 | The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma |
| Q35732360 | The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential. |
| Q36384268 | The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma |
| Q38989132 | The impact of hypoxia in pancreatic cancer invasion and metastasis. |
| Q34978975 | The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cells |
| Q98196633 | The role of histone methylation in the development of digestive cancers: a potential direction for cancer management |
| Q26768676 | The role of pluripotency factors to drive stemness in gastrointestinal cancer |
| Q33827679 | The secret origins and surprising fates of pancreas tumors |
| Q34589948 | The tumor suppressor rpl36 restrains KRAS(G12V)-induced pancreatic cancer |
| Q38123370 | The use of stem cells for pancreatic regeneration in diabetes mellitus |
| Q35077784 | The versatile functions of Sox9 in development, stem cells, and human diseases |
| Q28068998 | Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer |
| Q38162099 | Transcriptional control of mammalian pancreas organogenesis |
| Q64924277 | Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm. |
| Q28298678 | Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis |
| Q37702315 | Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9. |
| Q55001730 | Using CRISPR/Cas9 to Knock out Amylase in Acinar Cells Decreases Pancreatitis-Induced Autophagy. |
| Q36509087 | Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs |
| Q91816092 | Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice |
| Q91595040 | YAP and TAZ: a signalling hub of the tumour microenvironment |
| Q38817859 | p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells. |
| Q37080791 | β1 integrin is a crucial regulator of pancreatic β-cell expansion |
| Q47911126 | β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer |
| Q97534390 | κB-Ras and Ral GTPases regulate acinar to ductal metaplasia during pancreatic adenocarcinoma development and pancreatitis |
Search more.